Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

NCT01986088 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1008

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine With or Without Aura

Interventions

DRUG: Placebo
DRUG: Eletriptan 40 mg
DRUG: Eletriptan 80 mg
DRUG: Sumatriptan 50 mg
DRUG: Sumatriptan 100 mg

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.